Janney Montgomery Scott
HZNP

Janney Montgomery Scott’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Janney Montgomery Scott’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,816
Closed -$210K – 2805
2023
Q3 		$210K Sell
1,816
-1,585
-47% -$170K ﹤0.01% 2361
2023
Q2 		$350K Sell
3,401
-2,887
-46% -$305K ﹤0.01% 2138
2023
Q1 		$686K Sell
6,288
-293
-4% -$32.4K ﹤0.01% 1539
2022
Q4 		$749K Buy
6,581
+2,103
+47% +$175K ﹤0.01% 1524
2022
Q3 		$277K Sell
4,478
-2,870
-39% -$201K ﹤0.01% 2068
2022
Q2 		$592K Buy
7,348
+64
+0.9% +$6.06K ﹤0.01% 1512
2022
Q1 		$766K Buy
7,284
+2,835
+64% +$276K ﹤0.01% 1399
2021
Q4 		$479K Buy
4,449
+1,765
+66% +$193K ﹤0.01% 1751
2021
Q3 		$294K Sell
2,684
-1,514
-36% -$157K ﹤0.01% 1973
2021
Q2 		$393K Sell
4,198
-90
-2% -$8.28K ﹤0.01% 1781
2021
Q1 		$395K Buy
+4,288
New +$362K ﹤0.01% 1694
2020
Q3 		– Sell
-3,885
Closed -$216K – 2166
2020
Q2 		$216K Buy
+3,885
New +$166K ﹤0.01% 1799

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janney Montgomery Scott's HZNP Position: Q4 2023 in Review

Janney Montgomery Scott sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,816 shares — an estimated $210K sold.

Janney Montgomery Scott first reported a position in HZNP in Q2 2020 and held it in 12 quarters. The position peaked at $766K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Janney Montgomery Scott reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 1,816 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $210K.
  • Janney Montgomery Scott first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 12 quarters.
  • Janney Montgomery Scott's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $766K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.